Use of preparations containing anti-CD44 antibodies for the treatment of certain tumors and for the suppression of immune reactions

摘要

The present invention relates to the use of anti-CD44 antibodies of both the constant (sDC44) and the variable part of CD44 (vCD44) for treating certain tumours and other diseases associated with the degeneration and activation of Langerhans cells (LC) and dendritic cells (DC) inside a mammalian body, including humans, and for treating undesirable immune reactions. The invention further relates to an ex vivo cultivation process for producing dendritic cells.